Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03082391 · ClinicalTrials.gov registry record · NA
Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair
A NA study of Ventral Hernia, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT03082391: Completed NA study of Ventral Hernia, sponsored by The Cleveland Clinic.
NCT03082391 is a NA study of Ventral Hernia that has completed, run by The Cleveland Clinic. The registered enrollment target is 350 participants, above the 123-participant average among 18 other Ventral Hernia trials with a reported enrollment target (185% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03082391, a NA study of Ventral Hernia, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if mesh weight has an impact on postoperative pain, ventral hernia recurrence, incidence of deep wound infection, and overall quality of life following ventral hernia repair with mesh.
Primary Outcome
Pain Scores will be measured using the NIH Promis 3A Pain Scale. PROMIS® Pain Intensity 3A is a three-question instrument developed to measure the range of pain experienced in the week prior to assessment. The raw score (3-15) is converted into a T-score where 50 (SD 10) represents the average of people with at least mild pain, higher numbers (maximum 71.8) represent higher than average pain, and the lowest score (30.7) represents no pain.
Conditions Studied
Interventions
- DEVICE Heavy weight Mesh
- DEVICE Medium weight Mesh
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2017-03-14 |
| Est. Completion | 2020-05-28 |
| Phase | NA |
What the finished NCT03082391 record still lists
NCT03082391 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 123-participant average among 18 other Ventral Hernia trials with a reported enrollment target (185% higher).
The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 2 interventions - of which Heavy weight Mesh is the first listed.
NCT03082391 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03082391 about?
NCT03082391 is a clinical study titled "Heavy Weight Versus Medium Weight Mesh in Ventral Hernia Repair". The purpose of this study is to determine if mesh weight has an impact on postoperative pain, ventral hernia recurrence, incidence of deep wound infection, and overall quality of life following ventral hernia repair with mesh.
What is the current status of trial NCT03082391?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2017-03-14. Estimated completion is 2020-05-28.
What conditions does trial NCT03082391 study?
This clinical trial studies the following conditions: Ventral Hernia.
What interventions are being tested in trial NCT03082391?
The interventions under investigation include: Heavy weight Mesh (DEVICE), Medium weight Mesh (DEVICE).
Who is sponsoring clinical trial NCT03082391?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03082391 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03082391's enrollment target sits among peer trials
350 1st of 18 higher than 18 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI